HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

cetilistat

lipase inhibitor in randomized, placebo-controlled study of weight reduction in obese patients (3/2007)
Also Known As:
2-(hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one; ATL-962; 4H-3,1-Benzoxazin-4-one, 2-(hexadecyloxy)-6-methyl-
Networked: 12 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Khademi, Fatemeh: 1 article (01/2021)
2. Mahdavi, Mohammad: 1 article (01/2021)
3. Shahabadi, Nahid: 1 article (01/2021)
4. Zendehcheshm, Saba: 1 article (01/2021)
5. Mukesh, Sumit: 1 article (08/2020)
6. Sangamwar, Abhay T: 1 article (08/2020)
7. Talluri, M V N Kumar: 1 article (08/2020)
8. Tiwari, Shristy S: 1 article (08/2020)
9. Cai, Jian-Piao: 1 article (01/2020)
10. Cao, Jianli: 1 article (01/2020)

Related Diseases

1. Body Weight (Weight, Body)
2. Obesity
3. Hyperlipidemias (Hyperlipidemia)
4. Weight Loss (Weight Reduction)
5. Type 2 Diabetes Mellitus (MODY)

Related Drugs and Biologics

1. Lipase (Acid Lipase)
2. Orlistat (Xenical)
3. Lipids
4. Islet Amyloid Polypeptide
5. Ghrelin
6. Oxyntomodulin
7. Glucagon-Like Peptide 1 (GLP 1)
8. Leptin
9. Anti-Obesity Agents (Antiobesity Drugs)
10. Vaccines

Related Therapies and Procedures

1. Glycemic Control
2. Drug Therapy (Chemotherapy)